FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop
出版年份 2021 全文链接
标题
FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop
作者
关键词
Non-small-cell lung cancer, Gefitinib resistance, CASC9, FOXO3
出版物
LIFE SCIENCES
Volume 287, Issue -, Pages 120012
出版商
Elsevier BV
发表日期
2021-10-06
DOI
10.1016/j.lfs.2021.120012
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p
- (2019) Guodong Ma et al. DNA AND CELL BIOLOGY
- MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1
- (2019) Jing Zheng et al. PATHOLOGY & ONCOLOGY RESEARCH
- New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis
- (2019) Yutong Sun et al. Cancers
- Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
- (2019) Adrian D. Vickers et al. BMC CANCER
- Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
- (2019) Gugnoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer
- (2019) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- ncRNA-Encoded Peptides or Proteins and Cancer
- (2019) Jizhong Wang et al. MOLECULAR THERAPY
- LncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer
- (2019) Xiliu Chen et al. Molecular Therapy-Nucleic Acids
- LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
- (2019) Shuang Lin et al. Oncogenesis
- The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC
- (2018) Xuehao Li et al. CELL CYCLE
- miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT
- (2018) Demin Jiao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis
- (2018) Huy Gia Vuong et al. LUNG CANCER
- Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
- (2018) Jinnan Yue et al. ONCOGENE
- Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation
- (2018) James Chih-Hsin Yang et al. Journal of Thoracic Oncology
- Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis
- (2017) Zuyao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
- (2017) Yi-Long Wu et al. LUNG CANCER
- Targeted Therapy and Immunotherapy for Lung Cancer
- (2016) Evan C. Naylor et al. Surgical Oncology Clinics of North America
- Wnt Signaling Pathway in Non-Small Cell Lung Cancer
- (2013) D. J. Stewart JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now